APA (7th ed.) Citation

Berberich, A., Keßler, T., Pusch, S., Sahm, F., Schmitt, L., Fischer, M., . . . Wick, W. (2019). Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib. Clinical cancer research, 25(1), . https://doi.org/10.1158/1078-0432.CCR-18-1580

Chicago Style (17th ed.) Citation

Berberich, Anne, et al. "Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib." Clinical Cancer Research 25, no. 1 (2019). https://doi.org/10.1158/1078-0432.CCR-18-1580.

MLA (9th ed.) Citation

Berberich, Anne, et al. "Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib." Clinical Cancer Research, vol. 25, no. 1, 2019, https://doi.org/10.1158/1078-0432.CCR-18-1580.